finsmart-news_admin 
Parameta Solutions, the data and analytics division of TP ICAP Group, has made its over-the-counter (OTC) pricing and liquidity data available on Snowflake Marketplace. The move gives financial institutions immediate access to Parameta’s market insights directly through the Snowflake AI Data Cloud, without the need for data pipelines or duplication.
The integration supports critical use cases including liquidity risk modeling, pricing validation, and regulatory reporting. By making its data accessible via Snowflake’s infrastructure, Parameta aims to streamline how firms engage with independent OTC market data, particularly in opaque and fragmented markets.
“A step toward democratizing access to high-integrity OTC data”
Silvina Aldeco-Martinez, CEO of Parameta Solutions, commented, “Our collaboration with Snowflake has deepened through consistent delivery of Parameta’s high-quality OTC data to their customers. Joining Snowflake Marketplace is more than a distribution move—it’s a step toward democratizing access to high-integrity OTC data. We’re removing barriers, accelerating insight, and helping our clients see what others can’t in opaque markets.”
The offering spans a broad set of markets and asset classes, including interest rate and inflation derivatives, FX and money markets, fixed income and credit derivatives, equity derivatives, interest rate volatility, and energy and commodities such as oil, gas, coal, power, and metals.
Rinesh Patel, Global Head of Financial Services at Snowflake, said, “We’re hugely excited to bring Parameta Solutions to Snowflake Marketplace. Our collaboration enables our customers to seamlessly access high-quality OTC data and analytics to power key business critical processes from pricing strategies, risk management and regulatory obligations through our easy, connected and trusted platform.”
Snowflake Marketplace enables data and analytics delivery across a unified platform, reducing integration and procurement costs. Parameta’s onboarding marks a significant expansion of OTC market data availability within the platform and reflects ongoing demand from institutions seeking direct access to validated market data for compliance and strategic decision-making.
TP ICAP postpones Parameta IPO
TP ICAP recently record quarterly revenue by a boom in trading activity during a turbulent period for U.S. trade policy, though the firm has shelved plans for a U.S. listing of its data arm due to market instability. The interdealer broker posted a 10% rise in group revenue for the first quarter, reaching £629 million ($837 million) for the three months ending March 31, the strongest quarter in the company’s history.
The firm said heightened market volatility, largely linked to uncertainty around U.S. tariffs, had driven strong performance in its global broking and institutional trading units. Global broking revenue rose 14%, while Liquidnet — TP ICAP’s equities-focused platform — posted a 16% gain. Energy and commodities revenue remained flat, with the company citing a tight labor market for brokers as a limiting factor.
TP ICAP said it remains in line with market expectations for 2025 adjusted earnings before interest and tax, which stand at £346 million, based on a company-compiled analyst consensus. While recent U.S. dollar weakness has affected the group — with 60% of its revenue and 40% of costs denominated in dollars — the company said it is comfortable with current projections.
Despite the upbeat results, TP ICAP said it would delay the planned minority float of its data and analytics unit, Parameta Solutions, which had been slated for as early as the second quarter. The delay comes as a growing number of firms reconsider IPO plans in light of market swings linked to President Donald Trump’s tariff announcements. Santander-backed fintech firm Ebury also recently put off a £2 billion listing.
A U.S. listing of Parameta would have dealt a blow to London’s ongoing efforts to attract more high-growth listings, as U.K. markets face mounting competition from U.S. exchanges. TP ICAP’s decision to list Parameta overseas had already been seen as a vote of no confidence in the London IPO market.
That said, Parameta Solutions continues to draw investor interest amid a broader boom in demand for market data. The unit is part of a growing field of financial data providers that have seen high valuations in recent years. BlackRock’s recent $3.2 billion acquisition of Preqin and the London Stock Exchange’s $27 billion takeover of Refinitiv highlight the scale of investor appetite for these businesses.
